Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

This bill requires New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services for individuals aged 21-44 experiencing infertility, with coverage limited to three treatment cycles per person. Infertility is defined as failure to conceive after 12 months of regular, unprotected sex for those 21-34 years old, or six months for those 35-44 years old. Covered medical services include office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing, but not the drugs themselves for more than three cycles. The coverage is contingent on federal financial participation being available.